FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed is medication for treating diabetes, which contains part (1) and part (2), where part (1) contains coated particles, in which particles, including pioglitazone or its salt, are covered with lactose or sugar alcohol; and part (2), which contains glimeperide. As special case of combined medication claimed is multi-layered tablet.
EFFECT: increase of pioglitazone solubility in its application in one tablet with glimeperide.
15 cl, 2 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID MEDICATION | 2003 |
|
RU2357757C2 |
| SOLID PREPARATION | 2004 |
|
RU2359661C2 |
| METHOD OF OBTAINING OF PREPARATION WITH COVERING | 2004 |
|
RU2359671C2 |
| METHOD FOR TREATING METABOLISM DISORDERS MAINLY DIABETES CASES AND DISEASES OR STATES RELATED TO DIABETES | 2000 |
|
RU2280447C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION, CONTAINING GLUCOKINASE ACTIVATOR AND PPAR RECEPTOR ACTIVATOR, AND THEIR PREPARATION METHOD, AND THEIR USE | 2019 |
|
RU2781638C2 |
| PHARMACEUTICAL COMPOSITIONS | 2010 |
|
RU2532330C2 |
| GLYBURIDE CONTAINING COMPOSITION | 2001 |
|
RU2244707C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING AMINO COMPOUND | 2012 |
|
RU2607480C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A KATP CHANNEL BLOCKER, METHOD FOR PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2772875C1 |
| APPLICATION OF SIBUTRAMIN ANALOGS FOR PREVENTING DIABETES MELLITUS | 1997 |
|
RU2245709C2 |
